CLINICAL STUDY No. 1
DESCRIPTION
In vivo clinical study conducted over 8 weeks, using a blend of
Lactobacillus plantarum LP01®, Lactobacillus lactis LLC02® and Lactobacillus
delbrueckii LDD01®, carried out on 3,460 people with recurring
intestinal disorders.
RESULTS
After 2 months of daily intake, a significant improvement was
observed: digestive discomfort (bloating, discomfort) decreased in
frequency and intensity, and stool consistency returned to normal.
4x less bloating
in 8 weeks
CLINICAL STUDY No. 2
DESCRIPTION
Single-centre, randomised, double-blind, placebo-controlled clinical trial,
run for 8 weeks on 114 people with mild to moderate skin
imperfections. The supplement tested combined
three probiotic strains (Bifidobacterium breve BR03®, Lacticaseibacillus
casei LC03®, Ligilactobacillus salivarius LS03®) and botanical extracts
(aubergine lupeol and echinacea).
RESULTS
After 2 months of supplementation, participants who received the
probiotics and plant extracts combination showed a significant reduction in the
number of imperfections, as well as a better balance of the
skin microbiota, a decrease in
sebum production, in flaking and in porphyrins.
-56.7% imperfections
in 8 weeks
CLINICAL STUDY No. 3
DESCRIPTION
Randomised, double-blind, placebo-controlled crossover clinical
trial (BIFI-OBESE trial, NCT03261466), run for 8 weeks
in 101 young people (6 to 18 years old) with obesity associated with
insulin resistance. Participants received a probiotic
blend (Bifidobacterium breve BR03® and B. breve B632®) or a
placebo, alongside a suitable diet.
RESULTS
After 8 weeks of supplementation, a significant improvement
in insulin sensitivity was observed, both when fasting
and during the glucose tolerance test. Both groups saw
a decrease in weight and a general improvement in
metabolic parameters, but the probiotics group showed a
greater effect on blood sugar balance and on gut microbiota
function. No adverse effects were reported.
+0.65 points improvement in the insulin sensitivity index (ISI)
in 8 weeks
CLINICAL STUDY No. 4
DESCRIPTION
Randomised, double-blind, placebo-controlled clinical trial run for 6 weeks in 38 healthy volunteers. Participants received a daily probiotic blend (Lactobacillus fermentum LF16, L. rhamnosus LR06, L. plantarum LP01 and Bifidobacterium longum BL04) or a placebo, with monitoring of sleep, mood and emotional reactivity.
RESULTS
In the probiotic group, a significant improvement in mood was observed, with a reduction in negative feelings, anger and fatigue, as well as an improvement in sleep quality. Emotional acceptance scores were also higher than with the placebo after 6 weeks, suggesting a positive effect on emotional regulation. These results support the hypothesis that probiotics may contribute to psychological well-being through the gut-brain axis.
Significant improvement in sleep quality and less fatigue
in only 6 weeks
GOING FURTHER
FS-3B WHITE PAPER
The gut microbiota plays a central role in overall health. This white paper takes an in-depth look at how FS-3B works, the benefits demonstrated by research and its potential as an innovative strategy for supporting gut balance.
Download it now to access this exclusive content, which includes recent scientific data and clinical results.
OVER 300 CLINICAL STUDIES
The FS-3B tribiotic formulation is based on strains validated by more than 300 clinical studies. In the interest of transparency, and to make this data easier to reach, we provide it in a complete and clear document, designed to give you an overview you can consult directly.
START
TODAY
An advanced synergy of prebiotics, probiotics and postbiotics for a complete spectrum of action on the microbiota and on overall health.
